Concepedia

Tiffany Barnes

TB

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

2006

Affiliations

Gilead Sciences (United States)(Current)

San Francisco State University

University of California, Santa Cruz

University of California San Diego

Frederick National Laboratory for Cancer Research

Tiffany Barnes is an author at Gilead Sciences (United States) specializing in life sciences, antiviral therapy, and antiretroviral therapy.

ORCID

Publications per year

2006–2019

13

Publications

13

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

Datsen G. Wei, Vicki Chiang, Elizabeth Fyne et al. · PLoS Pathogens · 2014 · 281 citations · Full text

, , +17

TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy

So‐Yon Lim, Christa E. Osuna, Peter Hraber et al. · Science Translational Medicine · 2018 · 161 citations · Full text

, , +17

Differential inhibition of Wnt‐3a by Sfrp‐1, Sfrp‐2, and Sfrp‐3

Lisa M. Galli, Tiffany Barnes, Tina L. Cheng et al. · Developmental Dynamics · 2006 · 118 citations · Full text

, , +15

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Michael E. Abram, Rebecca Hluhanich, Derrick Goodman et al. · Antimicrobial Agents and Chemotherapy · 2013 · 111 citations · Full text

, , +17

Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube

Lisa M. Galli, Tiffany Barnes, Stephanie S. Secrest et al. · Development · 2007 · 98 citations · Full text

, , +17

1–5 of 13